Energized by inspiring nurses met at RCN 2017


We closed out the RCN Congress 2017 in Liverpool, UK on a royal high, energized by all of the nurses we met – amazing advocates for the best in patient care. Thanks to their inspiring stories, we gained an even deeper understanding of the acute need for reducing the complications of difficult venous access. They shared their insights on how Veinplicity® could help in their daily practices: from reducing stress, to negating the need for tourniquets, to assisting in trauma wards. Thank you for your support and enthusiasm. We also want to thank Joe Bailey, Andrew Corbett and the whole team at LINC Medical for working so hard to bring Veinplicity to nurses and patients throughout the UK.


NEWSROOM

The Veinplicity device is CE marked and registered as a Class IIa medical device in the European Union and as a Class II medical device in Canada. We are seeking FDA approval. The device is manufactured within the ISO 13485 standard in the United States.

Featured Posts
Follow Veinplicity
Archive
Categories